SCHEMBL10195488

SCHEMBL10195488

CCc1ccc(Oc2ccc([N+](=O)[O-])c(Cl)c2)cc1C1=C(O)CC(C)(C)CC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
WRN Q14191 2/20 0.41
ALDH1A1 P00352 9/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 3/20 0.36
MAPK1 P28482 2/20 0.36
MEN1 O00255 2/20 0.35
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
RECQL P46063 1/20 0.33
MCL1 Q07820 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TSHR P16473 2/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196196 0.86 MAPK1 (0.35) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10195477 0.86 NPC1 (0.33) MAPTALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL16181148 0.85 SMN1; SMN2 (0.39) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10195449 0.84 SMN1; SMN2 (0.39) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10195451 0.84 SMN1; SMN2 (0.39) MAPTALDH1A1KMT2ALMNASMN1; SMN2
SCHEMBL10195106 0.84 ALDH1A1 (0.42) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10194979 0.82 SMN1; SMN2 (0.39) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10195487 0.82 ALDH1A1 (0.38) MAPTWRNALDH1A1KMT2ALMNA
SCHEMBL10195484 0.82 CYP11B2 (0.39) ALDH1A1LMNASMN1; SMN2TSHRCASP1
SCHEMBL16351660 0.81 SMN1; SMN2 (0.36) MAPTWRNALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPT 3785/4885WRN 3643/4885ALDH1A1 45/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAPT 3903/4885WRN 4237/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.